Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
23
CATX Quote, Financials, Valuation and Earnings
Last price:
$1.85
Seasonality move
:
4.85%
Day range:
$1.74 - $1.89
52-week range:
$1.60 - $19.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.04x
P/B ratio:
0.47x
Volume:
1.7M
Avg. volume:
819.4K
1-year change:
-87.76%
Market cap:
$137.7M
Revenue:
--
EPS (TTM):
-$1.20
CATX Analysts' Consensus Rating
The 11 analysts providing 12-month price projections for Perspective Therapeutics shares anticipate an average target of $14.39, ranging from a low estimate of $6.00 to a high estimate of $21.00. This average target implies a growth of 673.81% compared to the current stock price of $1.86.
Consensus Price Target
$14.39
Highest Price Target
$21.00
Lowest Price Target
$6.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 9 | 10 | 10 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
CATX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 31x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Sell
44
TECS alert for Apr 11
Direxion Daily Technology Bear 3x Shares [TECS] is up 1.02% over the past day.
Sell
16
TECL alert for Apr 11
Direxion Daily Technology Bull 3x Shares [TECL] is down 1.54% over the past day.
Sell
47
WEBS alert for Apr 11
Direxion Daily Dow Jones Internet Bear 3X Shares [WEBS] is down 1.01% over the past day.
